Revisor Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318K Buy
1,274
+205
+19% +$51K 0.09% 242
2025
Q4
$265K Sell
1,069
-98
-8% -$26.8K 0.07% 259
2025
Q3
$306K Sell
1,167
-380
-25% -$92.4K 0.11% 207
2025
Q2
$354K Buy
1,547
+144
+10% +$30.8K 0.13% 193
2025
Q1
$314K Buy
1,403
+768
+121% +$212K 0.14% 163
2024
Q4
$208K Sell
635
-401
-39% -$126K 0.19% 116
2024
Q3
$311K Buy
1,036
+69
+7% +$21.1K 0.19% 121
2024
Q2
$319K Sell
967
-542
-36% -$192K 0.22% 107
2024
Q1
$564K Buy
1,509
+750
+99% +$277K 0.26% 104
2023
Q4
$267K Sell
759
-287
-27% -$102K 0.31% 91
2023
Q3
$392K Buy
1,046
+289
+38% +$112K 0.33% 69
2023
Q2
$290K Sell
757
-168
-18% -$60K 0.26% 109
2023
Q1
$320K Buy
+925
New +$270K 0.29% 85

Other funds holding WST